REG - GS Chain PLC - Allotment and Admission of New Shares

GS ChainAnnouncement

14/04/2026 08:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260414:nRSN2761Aa&default-theme=true

RNS Number : 2761A  GS Chain PLC  14 April 2026

GS CHAIN PLC

("GS Chain" or the "Company")

 

Allotment and Admission of New Shares

 

GS Chain Plc, a UK company admitted to the Equity Shares (Shell Companies)
category of the Official List of the Financial Conduct Authority (the
"Official List") and to the main market of the London Stock Exchange Group Plc
("Main Market"), is pleased to announce that further to the announcement made
by the Company on 4 March 2026 regarding the termination and settlement
agreement entered into with Citymeade Limited in relation to the Convertible
Investment Agreement dated 15 October 2025 ("Investment Agreement"), the
following additional information is disclosed in accordance with The Public
Offers and Admissions to Trading Regulations 2024 (POATRs) PRM 1.6.4R.

 

 1.   Details of the issuer:
 (a)  Name                                                     GS Chain Plc
 (b)  LEI                                                      984500K398M8C508B642
 2.   Details of the transferable securities admitted to trading:
 (a)  Name, type and identification code                       Ordinary shares of £0.000167 each;

                                                               ISIN: GB00BP38X172
 (b)  Regulated market                                         London Stock Exchange Plc's main market for listed securities
 (c)  Number of further securities admitted                    48,000,000
 (d)  Total number of securities in issue following admission  447,985,888
 (e)  Fungibility                                              Fully fungible with existing ordinary shares
 3.   Admission details:
 (a)  Date of admission                                        17 April 2026

 

Application has been made for the 48,000,000 shares, issued pursuant to the
Investment Agreement ("New Shares") to be admitted to trading on the main
market for listed securities of the London Stock Exchange Plc ("Admission").

 

Notwithstanding such application, dealings in the Company's ordinary shares
remain suspended and therefore dealings in the New Shares will not commence
until the publication by the Company of an FCA approved prospectus in relation
to its initial transaction, announced on 17 February 2026, or an announcement
that such initial transaction is not proceeding and the suspension is
subsequently lifted.

 

The New Shares will rank pari passu in all respects with the existing ordinary
shares of the Company.

 

Following Admission, the Company's issued share capital will consist of
447,985,888 ordinary shares of £0.000167 each. The Company does not hold any
ordinary shares in treasury. Accordingly, the total number of voting rights in
the Company will be 447,985,888. This figure may be used by shareholders as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The issue of the New Shares constitutes full and final settlement of the
obligations of the Company under the Investment Agreement, which has therefore
terminated in accordance with the terms of the termination and settlement
agreement announced on 4 March 2026.

 

 

- Ends -

 

For further information please contact:

 

 Paul Carroll, Director                        Paul@gschain.com (mailto:Paul@gschain.com)
 Bowsprit Partners Limited, Financial Adviser  +44 (0)203 883 4430

 John Treacy / Luis Brime

 

Caution regarding forward looking statement:

 

Certain statements in this announcement, are, or may be deemed to be, forward
looking statements. Forward looking statements are identified by their use of
terms and phrases such as ''believe'', ''could'', "should" ''envisage'',
''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect",
''will'' or the negative of those, variations or comparable expressions,
including references to assumptions. These forward-looking statements are not
based on historical facts but rather on the Directors' current expectations
and assumptions regarding the Company's future growth, results of operations,
performance, future capital and other expenditures (including the amount,
nature and sources of funding thereof), competitive advantages, business
prospects and opportunities. Such forward-looking statements reflect the
Directors' current beliefs and assumptions and are based on information
currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ADMEAXLDFDAKEFA



            Copyright 2019 Regulatory News Service, all rights reserved